Perrild H, Hegedüs L, Baastrup P C, Kayser L, Kastberg S
Department of Internal Medicine C, Bispebjerg Hospital, Copenhagen NV, Denmark.
Am J Psychiatry. 1990 Nov;147(11):1518-21. doi: 10.1176/ajp.147.11.1518.
Thyroid function was investigated in 100 manic-depressive patients. Goiter was more common in patients treated with lithium for 1-5 years (44%) or more than 10 years (50%) than in patients who never received lithium (16%). Smoking contributed significantly to thyroid size and goiter. In nonsmoking patients, ultrasonically determined thyroid volume was significantly related to treatment duration. The mechanism behind this increased thyroid volume is unclear, as most patients had normal serum thyrotropin levels and no thyroid autoimmunity. Subclinical or overt hypothyroidism was found in 4% and 21% of patients treated for 1-5 and more than 10 years, respectively. Since few hypothyroid patients had autoimmunity or goiter, lithium may affect the thyroid gland directly.
对100名躁郁症患者的甲状腺功能进行了研究。在接受锂治疗1至5年(44%)或超过10年(50%)的患者中,甲状腺肿比从未接受锂治疗的患者(16%)更为常见。吸烟对甲状腺大小和甲状腺肿有显著影响。在不吸烟的患者中,超声测定的甲状腺体积与治疗持续时间显著相关。甲状腺体积增加背后的机制尚不清楚,因为大多数患者血清促甲状腺激素水平正常且无甲状腺自身免疫。在接受治疗1至5年和超过10年的患者中,分别有4%和21%发现亚临床或显性甲状腺功能减退。由于很少有甲状腺功能减退患者存在自身免疫或甲状腺肿,锂可能直接影响甲状腺。